{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:19:46Z","timestamp":1784204386526,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejim.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T22:28:50Z","timestamp":1646778530000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Thrombotic events following Covid-19 vaccines compared to Influenza vaccines"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1331-8264","authenticated-orcid":false,"given":"Marcelo Gabriel","family":"Vallone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Luis","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio Matias","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Ferraris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro Francisco","family":"Cantarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda In\u00e9s","family":"Staneloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Ines","family":"Aliperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analia","family":"Ferloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Mezzarobba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Javier","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Florencia Grande","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.03.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2021.03.063","article-title":"Fast development of high-quality vaccines in a pandemic","author":"Pischel","year":"2021","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.ejim.2022.03.002_bib0002","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.002_bib0003","unstructured":"Swissmedic \u00a9C. Side effects of COVID-19 vaccines in Switzerland \u2013 update. Accessed June 11, 2021. https:\/\/www.swissmedic.ch\/swissmedic\/en\/home\/news\/coronavirus-covid-19\/nebenwirkungen-covid-19-impfungen-update.html."},{"key":"10.1016\/j.ejim.2022.03.002_bib0004","series-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination","year":"2021"},{"issue":"23","key":"10.1016\/j.ejim.2022.03.002_bib0005","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ejim.2022.03.002_bib0006","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ejim.2022.03.002_bib0007","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.002_bib0009","unstructured":"A.C. Pinho EMA's safety committee continues investigation of COVID-19 vaccine astrazeneca and thromboembolic events \u2013 further update. Published March 15, 2021. Accessed June 11, 2021. https:\/\/www.ema.europa.eu\/en\/news\/emas-safety-committee-continues-investigation-covid-19-vaccine-astrazeneca-thromboembolic-events."},{"issue":"28","key":"10.1016\/j.ejim.2022.03.002_bib0010","volume":"2","author":"Chan","year":"2021","journal-title":"Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca\/COVISHIELD Adenovirus Vector COVID-19 Vaccines. Science Briefs of the Ontario COVID-19 Science Advisory Table"},{"issue":"10","key":"10.1016\/j.ejim.2022.03.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30800","article-title":"Evaluation of a COVID-19 vaccine campaign and SARS-CoV-2 infection and mortality among adults aged 60 years and older in a middle-income country","volume":"4","author":"Macchia","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejim.2022.03.002_bib0012","unstructured":"Monitor p\u00fablico de vacunaci\u00f3n. Published February 23, 2021. Accessed June 27, 2021. https:\/\/www.argentina.gob.ar\/coronavirus\/vacuna\/aplicadas."},{"key":"10.1016\/j.ejim.2022.03.002_bib0013","unstructured":"Banco de recursos de comunicaci\u00f3n del ministerio de salud de la naci\u00f3n. Accessed June 27, 2021. https:\/\/bancos.salud.gob.ar\/recurso\/10deg-informe-de-seguridad-en-vacunas."},{"key":"10.1016\/j.ejim.2022.03.002_bib0014","author":"Ritchie","year":"2020","journal-title":"Coronavirus Pandemic (COVID-19)"},{"issue":"1","key":"10.1016\/j.ejim.2022.03.002_bib0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.13063\/2327-9214.1234","article-title":"Comparative effectiveness research using observational data: active comparators to emulate target trials with inactive comparators","volume":"4","author":"Huitfeldt","year":"2016","journal-title":"EGEMS"},{"issue":"43","key":"10.1016\/j.ejim.2022.03.002_bib0016","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.vaccine.2017.08.086","article-title":"Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the vaccine safety datalink","volume":"35","author":"Vickers","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ejim.2022.03.002_bib0017","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.20617","article-title":"An evidence-based causative classification system for acute ischemic stroke","volume":"58","author":"Ay","year":"2005","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ejim.2022.03.002_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2022.03.002_bib0019","doi-asserted-by":"crossref","first-page":"n1114","DOI":"10.1136\/bmj.n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study","volume":"373","author":"Potteg\u00e5rd","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.002_bib0020","article-title":"Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in people aged 75 years or older","author":"Jabagi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2022.03.002_bib0021","unstructured":"Oracle BI interactive dashboards-DAP. Accessed February 7, 2022. https:\/\/dap.ema.europa.eu\/analytics\/saw.dll?PortalPages."},{"key":"10.1016\/j.ejim.2022.03.002_bib0022","unstructured":"VAERS - About Us. Accessed February 7, 2022. https:\/\/vaers.hhs.gov\/about.html."},{"key":"10.1016\/j.ejim.2022.03.002_bib0023","doi-asserted-by":"crossref","first-page":"n1931","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2022.03.002_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res"},{"issue":"22","key":"10.1016\/j.ejim.2022.03.002_bib0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2022.03.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211040110","article-title":"Concern about the adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination","volume":"27","author":"Haimei","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.ejim.2022.03.002_bib0027","article-title":"Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination","author":"Ashrani","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2022.03.002_bib0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41421-021-00329-3","article-title":"Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines","volume":"7","author":"Liu","year":"2021","journal-title":"Cell Discov"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:50Z","timestamp":1760607350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"alternative-id":["S0953620522000929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.03.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic events following Covid-19 vaccines compared to Influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}